Immune response to pertussis vaccine in COPD patients. [PDF]
Feredj E +10 more
europepmc +1 more source
Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1
Background/Objectives: Pertussis, caused by Bordetella pertussis, remains a global health problem, despite high vaccine coverage. In countries with high acellular pertussis vaccine (aPV) coverage, pertactin-negative B.
Peter Goldstein +9 more
doaj +1 more source
Evaluation of acellular pertussis vaccine: comparisons among different strains of mice. [PDF]
Wei J +8 more
europepmc +1 more source
Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants. [PDF]
Knuutila A +9 more
europepmc +1 more source
Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria. [PDF]
Tahar Djebbar K +7 more
europepmc +1 more source
Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy. [PDF]
Alghounaim M +4 more
europepmc +1 more source
Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012-2017. [PDF]
McHugh L +11 more
europepmc +1 more source
Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model. [PDF]
Yang B +11 more
europepmc +1 more source

